The elevated levels of liver Dyrk1b strongly correlated with NASH diagnosis but not with its severity, implicating its role in disease pathogenesis in humans as opposed to disease progression (Figure 1J). The gene discussed is DYRK1B; the disease is metabolic dysfunction-associated steatohepatitis.